NIH-funded research R01 grant

Epigenetic changes linked to gut barrier problems in HIV, and how to fix them

Official title: Epigenetic modulation of intestinal epithelial dysfunction in HIV/SIV infection

Funded at Texas Biomedical Research Institute · NIH-11328410 · Data updated 2026-11-12

A study exploring how DNA methylation and open chromatin in the gut lining contribute to barrier dysfunction in people living with HIV onART, with potential ways to improve gut health and reduce inflammation.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTexas Biomedical Research Institute
NIH-funded
Lab location1 site (San Antonio, United States)
Project startSeptember 1, 2026
Project endJuly 31, 2030
Funding year2026
Award (this year)$905,998
NIH project number1R01DK146767-01
Project IDNIH-11328410 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults living with HIV on stable ART who have gut-related symptoms or inflammation markers and are willing to provide tissue samples or participate in related analyses.

Less likely to help

Patients without HIV or who are not on ART would not benefit from this specific research.

What this research studies

People living with HIV on effective ART can still have gut barrier problems that lead to inflammation. This project looks at epigenetic changes in gut cells and how they may drive epithelial dysfunction, using advanced techniques to map DNA methylation and chromatin accessibility in colon tissue. The goal is to identify epigenetic targets that could be modulated to restore barrier integrity and reduce systemic inflammation. The research includes studies in primate models and may inform future therapies to improve gut health in HIV patients.

Why it matters

Potential benefit: If successful, the work could reveal new targets to restore gut barrier function and lower inflammation for people with HIV.

How similar studies have gone: Preliminary data in primate models show epigenetic changes associated with gut epithelial dysfunction, suggesting a promising avenue.

Where this research is happening

  • Texas Biomedical Research Institute
    San Antonio, United States
    Active

Researchers

  • Principal investigator: Mohan, Mahesh — Texas Biomedical Research Institute
  • Study coordinator: Mohan, Mahesh

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.